Skip to content
iStock-1500823492 (1) iStock-1500823492 (1)

Navigate Regulatory Affairs with Precision

Your strategic partner in achieving global regulatory success.
Precision’s Global Regulatory Affairs team combines strategic foresight and operational expertise with a foundation in scientific, medical, and clinical knowledge to accelerate your journey from development to registration and market access.
iStock-1401326975 (1)

Global Regulatory Affairs expertise with local insights

Precision delivers deep strategic insight with operational excellence in regulatory affairs, guiding sponsors through clinical development, registration, and market access. Our approach is characterized by:
  • Global and Regional Leadership: Our team comprises experienced regulatory experts who stay abreast of the latest regulatory changes, safeguarding alignment of your project with current guidelines and best practices.
  • Regulatory Oversight: A structured escalation pathway and integrated expertise ensure your project receives the focused attention it deserves, mitigating risks and streamlining progress.
  • Unified Communication: Precision offers a single point of contact at the project level, enhancing clarity and efficiency in communication and decision-making.

This integrated approach affirms that Precision for Medicine not only provides global reach but does so with the nuanced understanding necessary for navigating diverse regulatory landscapes effectively.

Comprehensive regulatory services tailored to your needs 

In the ever-evolving regulatory landscape, success hinges on strategic insight and operational expertise. Precision for Medicine offers tailored regulatory consulting services and solutions designed to seamlessly integrate with your drug development journey, ensuring not just compliance but strategic advantage. Our suite of services, from program management to pediatric planning, is crafted to guide you through regulatory milestones with precision and foresight. Discover how our dedicated experts can propel your project towards regulatory and commercial success.

  • FSP Governance

    Streamlined Regulatory Program Oversight

    Precision's regulatory insight offers a strategic partnership, providing input   across your drug development lifecycle. By aligning with your goals and timelines, we navigate complexities to maintain momentum toward milestones. Engage with our experts for a tailored approach that integrates seamlessly with your objectives, delivering operational excellence and strategic foresight.
  • CDP_CTA banner 2 (1)

    Navigating Expedited Pathways

    Accelerate your journey through regulatory landscapes with Precision’s expertise in expedited programs. From identifying eligibility to submission, our team expertly guides your therapy through Fast Track, Breakthrough Therapy Designation, PRIME and more, optimizing your route to market with strategic precision.
  • Precision FSP Program Support

    Regulatory Authority Meetings

    Master your regulatory meetings with confidence. Precision prepares you for critical discussions with health authorities, offering comprehensive support from meeting requests and briefing package preparation to strategic meeting facilitation, so your objectives can be communicated clearly and chart a path forward.
  • Precision FSP Managed Solutions

    Expert Regulatory Submission Preparation

    Precision transforms the complexity of regulatory submissions into a streamlined process. With meticulous attention to detail, we manage INDs, CTAs, NDAs, BLAs, MAAs , ODDs, PIP/PSP and more, ensuring compliance and timely submissions. Let us navigate the regulatory formatting and compilation of eCTD submissions, so you can focus on innovation.
  • CTA banner_CTD

    Advancing Orphan Drug Designations

    Unlock the potential of your orphan drug with Precision's strategic guidance. We navigate the orphan designation process, maximizing the benefits of tax credits, user fee waivers and market exclusivity to bring your rare disease therapy to those in need.
  • iStock-1442379947

    Strategic Pediatric Regulatory Pathways

    Precision specializes in pediatric planning for regulatory success, confirming your research meets specific requirements for studies involving younger populations. We guide you through the regulatory framework, focusing on strategy, submission, and negotiations with health authorities to align with pediatric study plans and fulfill regulatory obligations.

Empowering IVD/CDx & commercial success

Precision’s specialized teams bridge the divide between regulatory strategy and market success. Our In Vitro Diagnostics (IVD) and Companion Diagnostics (CDx) Regulatory team ensure your products not only meet global regulatory standards but also excel in the competitive marketplace. Similarly, our commercialization division, Precision AQ, provides the necessary foresight and strategies to navigate the complexities of market access, payer engagement, and health economics, paying the way for your product’s success. This holistic model underscores our commitment to turning regulatory achievements into commercial victories.

  • Discover IVD/CDx Regulatory Mastery
    iStock-1346675527 (3)

    IVD/CDx Regulatory Mastery

    From global assay testing to comprehensive registrations, Precision's IVD Regulatory Affairs team brings over a century of experience in diagnostics, offering tailored regulatory strategies that ensure your innovations achieve global compliance and success.

    Explore IVD/CDx
  • Discover Your Path to Commercialization
    business-men

    Your Path to Commercialization

    Seamlessly transition from regulatory approvals to market triumph with Precision AQ. Our commercialization experts guide your product through HEOR preparations, market access strategies,and impactful payer and HCP engagements, setting the stage for your success.

    Explore Commercialization

Regulatory insights from Precision’s experts

Stay ahead with the latest regulatory insights from Precision’s team of experts. Discover valuable perspectives, updates, and strategies to navigate the regulatory environment effectively.

Read: How to launch a clinical trial in South Korea: Investigational New Drug Application Process How to launch a clinical trial in South Korea: Investigational New Drug Application Process

Clinical Trials - Regulatory

How to launch a clinical trial in South Korea: Investigational New Drug Application Process

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=185416008310, hs_child_table_id=0, hs_updated_at=1737992478996, hs_published_at=1738849393727, description=MeeHyun has over 15 years of experience with MFDS, multinational pharmaceutical companies, and CROs, specializing in regulatory affairs and clinical development. In her current role, MeeHyun supports regulatory affairs activities in Australia and South Korea. She is a certified pharmacist in South Korea and holds a BSc in pharmacy, avatar=Image{width=1500,height=2100,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/MeeHyun%20Byun.jpg',altText='MeeHyun Byun',fileId=185417806426}, lastname=Byun, hs_initial_published_at=1737992486362, hs_created_by_user_id=26433386, hs_created_at=1737992417320, hs_is_edited=false, hs_deleted_at=0, name=MeeHyun, job=Senior Regulatory Associate, slug=meehyun-byun, hs_updated_by_user_id=26433386}, second={hs_id=167906611101, hs_child_table_id=0, hs_updated_at=1724924613816, hs_published_at=1738849393727, avatar=Image{width=600,height=700,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Helene-Ormandy.png',altText='Helene-Ormandy',fileId=168387434767}, lastname=Ormandy, PhD, hs_initial_published_at=1716212950394, hs_created_by_user_id=2737751, hs_created_at=1716212897654, hs_is_edited=false, hs_deleted_at=0, name=Helen, job=Senior Director, Clinical Operations, slug=helen-ormandy, hs_updated_by_user_id=26433386}, third={}})
  • MeeHyun B. avatar

    MeeHyun B.

  • Helen O. avatar

    Helen O.

Discover
Read: Gene Therapy Assays: Regulatory Compliance with Unified Immunogenicity Gene Therapy Assays: Regulatory Compliance with Unified Immunogenicity

Translational Research - Regulatory - Assays - Gene Therapies

Gene Therapy Assays: Regulatory Compliance with Unified Immunogenicity

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778875, hs_child_table_id=0, hs_updated_at=1716454216458, hs_published_at=1738849393727, description=Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Deb%20Phippard.webp',altText='Deb Phippard',fileId=165892372605}, linkedin=https://www.linkedin.com/in/deb-phippard-103b54, team=[{id=163072475007, name='Precision for Medicine Leadership'}], hs_name=, hs_path=, lastname=Phippard, PhD, hs_initial_published_at=1716212769184, hs_created_at=1709645745106, hs_is_edited=false, hs_deleted_at=0, name=Deborah, job= Chief Scientific Officer, slug=deborah-phippard, email=, hs_updated_by_user_id=26433386}, second={hs_id=159488778840, hs_child_table_id=0, hs_updated_at=1716132440837, hs_published_at=1738849393727, description=Maham Ansari, MS, RAC is a Senior Director, IVD Regulatory Affairs. Her focus is on companion diagnostic co-development programs, where she leverages her regulatory expertise to secure approvals in the US, Europe and beyond for companion diagnostics with a specific focus on gene therapy. She brings more than 16 years of global regulatory leadership experience in the medical device and in vitro diagnostics industry, spanning major multinationals to small start-ups, including full life cycle management across all stages of product development, execution of global regulatory strategies, and post-market surveillance.sh, avatar=Image{width=710,height=710,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Maham_Ansari.png',altText='Maham_Ansari',fileId=167373022876}, linkedin=https://www.linkedin.com/in/maham-ansari-ms-rac-6a735739, hs_name=, hs_path=, lastname=Ansari, hs_initial_published_at=1716212769184, hs_created_at=1709645745071, hs_is_edited=false, hs_deleted_at=0, name=Maham, job=, slug=maham-ansari, email=, hs_updated_by_user_id=26433386}, third={}})
  • Deborah P. avatar

    Deborah P.

  • Maham A. avatar

    Maham A.

Discover
Read: What Is an FDA Breakthrough Therapy Designation? What Is an FDA Breakthrough Therapy Designation?

Clinical Trials - Regulatory

What Is an FDA Breakthrough Therapy Designation?

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=167363064857, hs_child_table_id=0, hs_updated_at=1719905898183, hs_published_at=1738849393727, description=Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors., avatar=Image{width=553,height=580,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Harpreet-Singh2.png',altText='Harpreet-Singh2',fileId=171747124346}, linkedin=https://www.linkedin.com/in/harpreetsinghmd/, team=[{id=163072475007, name='Precision for Medicine Leadership'}], lastname=Singh, MD, hs_initial_published_at=1715692570942, hs_created_by_user_id=2737751, hs_created_at=1715692477118, hs_is_edited=false, hs_deleted_at=0, name=Harpreet, job=Chief Medical Officer, slug=harpreet-singh, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Harpreet Singh, MD avatar

    Harpreet Singh, MD

Discover

Advance therapeutic breakthroughs with Precision

Explore the breadth of our expertise in therapeutics and modalities as we lead your novel treatments in Oncology, Rare Diseases and beyond, from the groundbreaking idea to clinical realization.

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore
  • Discover Explore
    Manufacturing

    Manufacturing
    Solutions

    Pioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.

    Explore